Inovio Pharma (INO) Misses Q1 EPS by 4c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. MSFT
6. NVDA
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Inovio Pharma (INO) Misses Q1 EPS by 4c, Revenues Miss

Epidemic response group to invest up to $384 mln in Novavax's COVID-19 vaccine

May 11, 2020 4:07 PM EDT

(Reuters) - The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $384 million to help develop and produce Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine candidate, the company said on Monday, sending its shares up 31.2% in extended trading.

CEPI, which was set up to fight emerging epidemics, said in March it would invest... More

Inovio Pharmaceuticals (INO) PT Raised to $9 at RBC Capital

May 7, 2020 6:14 AM EDT

RBC Capital analyst Gregory Renza raised the price target on Inovio Pharmaceuticals (NASDAQ: INO) to $9.00 (from $7.00) while maintaining a Sector Perform rating.... More